Edward Lifesciences Corporation received its European CE Mark for the SAPIEN 3 Ultra, a new system for transcatheter aortic valve replacement.

03 January 2019 Written by CN1699 Services Article viewed 12 times (0 times in the last week)

The Edward SAPIEN 3 Ultra system is designed to help simplify and improve efficiency of procedures. It incorporates enhancements to the valve, which results in exceptional outcomes.

Read more at Edwards.

Image from Edwards

Karen C

Off-Shore Manager - CN1699 Services